JenaValve is a medical device innovator dedicated to improving transcatheter aortic valve replacement (TAVR) therapies. The Company’s Trilogy THV System is a TAVR system designed to treat patients with symptomatic, severe AR, and symptomatic, severe aortic stenosis who are at high surgical risk.